{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T14:01:36Z","timestamp":1790690496299,"version":"4.1.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,1,30]],"date-time":"2024-01-30T00:00:00Z","timestamp":1706572800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,1,30]],"date-time":"2024-01-30T00:00:00Z","timestamp":1706572800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["IG-23470"],"award-info":[{"award-number":["IG-23470"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["ID 22737"],"award-info":[{"award-number":["ID 22737"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["RF-2016-02361054"],"award-info":[{"award-number":["RF-2016-02361054"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell. Mol. Life Sci."],"published-print":{"date-parts":[[2024,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Aminopeptidase N\/CD13, a membrane-bound enzyme upregulated in tumor vasculature and involved in angiogenesis, can be used as a receptor for the targeted delivery of drugs to tumors through ligand-directed targeting approaches. We describe a novel peptide ligand (VGCARRYCS, called \u201cG4\u201d) that recognizes CD13 with high affinity and selectivity. Enzymological and computational studies showed that G4 is a competitive inhibitor that binds to the catalytic pocket of CD13 through its N-terminal region. Fusing the peptide C-terminus to tumor necrosis factor-alpha (TNF) or coupling it to a biotin\/avidin complex causes loss of binding and inhibitory activity against different forms of CD13, including natural or recombinant ectoenzyme and a membrane form expressed by HL60 promyelocytic leukemia cells (likely due to steric hindrance), but not binding to a membrane form of CD13 expressed by endothelial cells (ECs). Furthermore, G4-TNF systemically administered to tumor-bearing mice exerted anticancer effects through a CD13-targeting mechanism, indicating the presence of a CD13 form in tumor vessels with an accessible binding site. Biochemical studies showed that most CD13 molecules expressed on the surface of ECs are catalytically inactive. Other functional assays showed that these molecules can promote endothelial cell adhesion to plates coated with G4-avidin complexes, suggesting that the endothelial form of CD13 can exert catalytically independent biological functions. In conclusion, ECs express a catalytically inactive form of CD13 characterized by an accessible conformation that can be selectively targeted by G4-protein conjugates. This form of CD13 may represent a specific target receptor for ligand-directed targeted delivery of therapeutics to tumors.<\/jats:p>","DOI":"10.1007\/s00018-023-05102-1","type":"journal-article","created":{"date-parts":[[2024,1,30]],"date-time":"2024-01-30T10:02:41Z","timestamp":1706608961000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["A novel aminopeptidase N\/CD13 inhibitor selectively targets an endothelial form of CD13 after coupling to proteins"],"prefix":"10.1007","volume":"81","author":[{"given":"Giulia","family":"Anderluzzi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michela","family":"Ghitti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Maria","family":"Gasparri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Tai\u00e8","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelina","family":"Sacchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Gori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annapaola","family":"Andolfo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Pozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanna","family":"Musco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7231-9569","authenticated-orcid":false,"given":"Flavio","family":"Curnis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo","family":"Corti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,1,30]]},"reference":[{"key":"5102_CR1","first-page":"722","volume":"60","author":"R Pasqualini","year":"2000","unstructured":"Pasqualini R, Koivunen E, Kain R, Lahdenranta J, Sakamoto M, Stryhn A, Ashmun RA, Shapiro LH, Arap W, Ruoslahti E (2000) Aminopeptidase N is a receptor for tumor-homing peptides and a target for inhibiting angiogenesis. Can Res 60:722\u2013727","journal-title":"Can Res"},{"key":"5102_CR2","first-page":"867","volume":"62","author":"F Curnis","year":"2002","unstructured":"Curnis F, Arrigoni G, Sacchi A, Fischetti L, Arap W, Pasqualini R, Corti A (2002) Differential binding of drugs containing the NGR motif to CD13 isoforms in tumor vessels, epithelia, and myeloid cells. Can Res 62:867\u2013874","journal-title":"Can Res"},{"key":"5102_CR3","doi-asserted-by":"publisher","first-page":"3272","DOI":"10.1096\/fj.07-8273com","volume":"21","author":"J Lahdenranta","year":"2007","unstructured":"Lahdenranta J, Sidman RL, Pasqualini R, Arap W (2007) Treatment of hypoxia-induced retinopathy with targeted proapoptotic peptidomimetic in a mouse model of disease. Faseb J 21:3272\u20133278","journal-title":"Faseb J"},{"key":"5102_CR4","doi-asserted-by":"publisher","first-page":"2681","DOI":"10.1161\/01.ATV.0000245807.65714.0b","volume":"26","author":"A Buehler","year":"2006","unstructured":"Buehler A, van Zandvoort MA, Stelt BJ, Hackeng TM, Schrans-Stassen BH, Bennaghmouch A, Hofstra L, Cleutjens JP, Duijvestijn A, Smeets MB, de Kleijn DP, Post MJ, de Muinck ED (2006) cNGR: a novel homing sequence for CD13\/APN targeted molecular imaging of murine cardiac angiogenesis in vivo. Arterioscler Thromb Vasc Biol 26:2681\u20132687","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"5102_CR5","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1369\/jhc.2010.956644","volume":"59","author":"P Di Matteo","year":"2011","unstructured":"Di Matteo P, Arrigoni GL, Alberici L, Corti A, Gallo-Stampino C, Traversari C, Doglioni C, Rizzardi GP (2011) Enhanced expression of CD13 in vessels of inflammatory and neoplastic tissues. J Histochem Cytochem 59:47\u201359","journal-title":"J Histochem Cytochem"},{"key":"5102_CR6","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1006\/cimm.2000.1629","volume":"201","author":"AN Santos","year":"2000","unstructured":"Santos AN, Langner J, Herrmann M, Riemann D (2000) Aminopeptidase N\/CD13 is directly linked to signal transduction pathways in monocytes. Cell Immunol 201:22\u201332","journal-title":"Cell Immunol"},{"key":"5102_CR7","doi-asserted-by":"publisher","first-page":"3310","DOI":"10.1074\/jbc.M109.060418","volume":"285","author":"M Drag","year":"2010","unstructured":"Drag M, Bogyo M, Ellman JA, Salvesen GS (2010) Aminopeptidase fingerprints, an integrated approach for identification of good substrates and optimal inhibitors. J Biol Chem 285:3310\u20133318","journal-title":"J Biol Chem"},{"key":"5102_CR8","doi-asserted-by":"publisher","first-page":"36804","DOI":"10.1074\/jbc.M112.398842","volume":"287","author":"AH Wong","year":"2012","unstructured":"Wong AH, Zhou D, Rini JM (2012) The X-ray crystal structure of human aminopeptidase N reveals a novel dimer and the basis for peptide processing. J Biol Chem 287:36804\u201336813","journal-title":"J Biol Chem"},{"key":"5102_CR9","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/j.jmb.2005.03.070","volume":"349","author":"OJ Kyrieleis","year":"2005","unstructured":"Kyrieleis OJ, Goettig P, Kiefersauer R, Huber R, Brandstetter H (2005) Crystal structures of the tricorn interacting factor F3 from Thermoplasma acidophilum, a zinc aminopeptidase in three different conformations. J Mol Biol 349:787\u2013800","journal-title":"J Mol Biol"},{"key":"5102_CR10","doi-asserted-by":"publisher","first-page":"5302","DOI":"10.1038\/s41467-021-25564-w","volume":"12","author":"Z Maben","year":"2021","unstructured":"Maben Z, Arya R, Georgiadis D, Stratikos E, Stern LJ (2021) Conformational dynamics linked to domain closure and substrate binding explain the ERAP1 allosteric regulation mechanism. Nat Commun 12:5302","journal-title":"Nat Commun"},{"key":"5102_CR11","doi-asserted-by":"publisher","first-page":"46045","DOI":"10.1038\/srep46045","volume":"7","author":"C Santiago","year":"2017","unstructured":"Santiago C, Mudgal G, Reguera J, Recacha R, Albrecht S, Enjuanes L, Casasnovas JM (2017) Allosteric inhibition of aminopeptidase N functions related to tumor growth and virus infection. Sci Rep 7:46045","journal-title":"Sci Rep"},{"key":"5102_CR12","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.molmed.2008.06.003","volume":"14","author":"P Mina-Osorio","year":"2008","unstructured":"Mina-Osorio P (2008) The moonlighting enzyme CD13: old and new functions to target. Trends Mol Med 14:361\u2013371","journal-title":"Trends Mol Med"},{"key":"5102_CR13","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1182\/blood.V97.3.652","volume":"97","author":"SV Bhagwat","year":"2001","unstructured":"Bhagwat SV, Lahdenranta J, Giordano R, Arap W, Pasqualini R, Shapiro LH (2001) CD13\/APN is activated by angiogenic signals and is essential for capillary tube formation. Blood 97:652\u2013659","journal-title":"Blood"},{"key":"5102_CR14","doi-asserted-by":"publisher","first-page":"639","DOI":"10.2174\/092986707780059571","volume":"14","author":"Y Luan","year":"2007","unstructured":"Luan Y, Xu W (2007) The structure and main functions of aminopeptidase N. Curr Med Chem 14:639\u2013647","journal-title":"Curr Med Chem"},{"key":"5102_CR15","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/0268-960X(92)90020-Q","volume":"6","author":"K Razak","year":"1992","unstructured":"Razak K, Newland AC (1992) The significance of aminopeptidases and haematopoietic cell differentiation. Blood Rev 6:243\u2013250","journal-title":"Blood Rev"},{"key":"5102_CR16","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/S0167-5699(98)01398-X","volume":"20","author":"D Riemann","year":"1999","unstructured":"Riemann D, Kehlen A, Langner J (1999) CD13\u2013not just a marker in leukemia typing. Immunol Today 20:83\u201388","journal-title":"Immunol Today"},{"key":"5102_CR17","doi-asserted-by":"publisher","first-page":"2593","DOI":"10.4049\/jimmunol.157.6.2593","volume":"157","author":"H Chen","year":"1996","unstructured":"Chen H, Kinzer CA, Paul WE (1996) p161, a murine membrane protein expressed on mast cells and some macrophages, is mouse CD13\/aminopeptidase N. J Immunol 157:2593\u20132600","journal-title":"J Immunol"},{"key":"5102_CR18","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1096\/fasebj.7.2.8440407","volume":"7","author":"A Taylor","year":"1993","unstructured":"Taylor A (1993) Aminopeptidases: structure and function. FASEB J 7:290\u2013298","journal-title":"FASEB J"},{"key":"5102_CR19","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1136\/jcp.47.1.43","volume":"47","author":"J Dixon","year":"1994","unstructured":"Dixon J, Kaklamanis L, Turley H, Hickson ID, Leek RD, Harris AL, Gatter KC (1994) Expression of aminopeptidase-n (CD 13) in normal tissues and malignant neoplasms of epithelial and lymphoid origin. J Clin Pathol 47:43\u201347","journal-title":"J Clin Pathol"},{"key":"5102_CR20","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1038\/81183","volume":"18","author":"F Curnis","year":"2000","unstructured":"Curnis F, Sacchi A, Borgna L, Magni F, Gasparri A, Corti A (2000) Enhancement of tumor necrosis factor alpha antitumor immunotherapeutic properties by targeted delivery to aminopeptidase N (CD13). Nat Biotechnol 18:1185\u20131190","journal-title":"Nat Biotechnol"},{"key":"5102_CR21","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.2174\/138920111796117373","volume":"12","author":"A Corti","year":"2011","unstructured":"Corti A, Curnis F (2011) Tumor vasculature targeting through NGR peptide-based drug delivery systems. Curr Pharm Biotechnol 12:1128\u20131134","journal-title":"Curr Pharm Biotechnol"},{"key":"5102_CR22","doi-asserted-by":"publisher","first-page":"3648","DOI":"10.1182\/bloodadvances.2020002270","volume":"4","author":"AJM Ferreri","year":"2020","unstructured":"Ferreri AJM, Calimeri T, Ponzoni M, Curnis F, Conte GM, Scarano E, Rrapaj E, De Lorenzo D, Cattaneo D, Fallanca F, Nonis A, Foppoli M, Lopedote P, Citterio G, Politi LS, Sassone M, Angelillo P, Guggiari E, Steffanoni S, Tarantino V, Ciceri F, Bordignon C, Anzalone N, Corti A (2020) Improving the antitumor activity of R-CHOP with NGR-hTNF in primary CNS lymphoma: final results of a phase 2 trial. Blood Adv 4:3648\u20133658","journal-title":"Blood Adv"},{"key":"5102_CR23","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1182\/blood.2019000633","volume":"134","author":"AJM Ferreri","year":"2019","unstructured":"Ferreri AJM, Calimeri T, Conte GM, Cattaneo D, Fallanca F, Ponzoni M, Scarano E, Curnis F, Nonis A, Lopedote P, Citterio G, Politi LS, Foppoli M, Girlanda S, Sassone M, Perrone S, Cecchetti C, Ciceri F, Bordignon C, Corti A, Anzalone N (2019) R-CHOP preceded by blood-brain barrier permeabilization with engineered tumor necrosis factor-alpha in primary CNS lymphoma. Blood 134:252\u2013262","journal-title":"Blood"},{"key":"5102_CR24","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1007\/s12274-016-1035-8","volume":"9","author":"F Curnis","year":"2016","unstructured":"Curnis F, Fiocchi M, Sacchi A, Gori A, Gasparri A, Corti A (2016) NGR-tagged nano-gold: a new CD13-selective carrier for cytokine delivery to tumors. Nano Res 9:1393\u20131408","journal-title":"Nano Res"},{"key":"5102_CR25","first-page":"2917","volume":"59","author":"A Gasparri","year":"1999","unstructured":"Gasparri A, Moro M, Curnis F, Sacchi A, Pagano S, Veglia F, Casorati G, Siccardi AG, Dellabona P, Corti A (1999) Tumor pretargeting with avidin improves the therapeutic index of biotinylated tumor necrosis factor alpha in mouse models. Can Res 59:2917\u20132923","journal-title":"Can Res"},{"key":"5102_CR26","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1021\/acs.jcim.7b00052","volume":"57","author":"D Sindhikara","year":"2017","unstructured":"Sindhikara D, Spronk SA, Day T, Borrelli K, Cheney DL, Posy SL (2017) Improving accuracy, diversity, and speed with prime macrocycle conformational sampling. J Chem Inf Model 57:1881\u20131894","journal-title":"J Chem Inf Model"},{"key":"5102_CR27","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s10822-013-9644-8","volume":"27","author":"GM Sastry","year":"2013","unstructured":"Sastry GM, Adzhigirey M, Day T, Annabhimoju R, Sherman W (2013) Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments. J Comput Aided Mol Des 27:221\u2013234","journal-title":"J Comput Aided Mol Des"},{"key":"5102_CR28","doi-asserted-by":"publisher","first-page":"6177","DOI":"10.1021\/jm051256o","volume":"49","author":"RA Friesner","year":"2006","unstructured":"Friesner RA, Murphy RB, Repasky MP, Frye LL, Greenwood JR, Halgren TA, Sanschagrin PC, Mainz DT (2006) Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes. J Med Chem 49:6177\u20136196","journal-title":"J Med Chem"},{"key":"5102_CR29","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1002\/prot.10613","volume":"55","author":"MP Jacobson","year":"2004","unstructured":"Jacobson MP, Pincus DL, Rapp CS, Day TJ, Honig B, Shaw DE, Friesner RA (2004) A hierarchical approach to all-atom protein loop prediction. Proteins 55:351\u2013367","journal-title":"Proteins"},{"key":"5102_CR30","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1016\/j.jmb.2007.05.022","volume":"372","author":"E Krissinel","year":"2007","unstructured":"Krissinel E, Henrick K (2007) Inference of macromolecular assemblies from crystalline state. J Mol Biol 372:774\u2013797","journal-title":"J Mol Biol"},{"key":"5102_CR31","doi-asserted-by":"publisher","first-page":"17966","DOI":"10.1073\/pnas.1210123109","volume":"109","author":"L Chen","year":"2012","unstructured":"Chen L, Lin YL, Peng G, Li F (2012) Structural basis for multifunctional roles of mammalian aminopeptidase N. Proc Natl Acad Sci U S A 109:17966\u201317971","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5102_CR32","doi-asserted-by":"publisher","first-page":"34520","DOI":"10.1074\/jbc.M114.566802","volume":"289","author":"C Liu","year":"2014","unstructured":"Liu C, Yang Y, Chen L, Lin YL, Li F (2014) A unified mechanism for aminopeptidase N-based tumor cell motility and tumor-homing therapy. J Biol Chem 289:34520\u201334529","journal-title":"J Biol Chem"},{"key":"5102_CR33","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1021\/bi971705p","volume":"37","author":"N Luciani","year":"1998","unstructured":"Luciani N, Marie-Claire C, Ruffet E, Beaumont A, Roques BP, Fournie-Zaluski MC (1998) Characterization of Glu350 as a critical residue involved in the N-terminal amine binding site of aminopeptidase N (EC 3.4.11.2): insights into its mechanism of action. Biochemistry 37:686\u2013692","journal-title":"Biochemistry"},{"key":"5102_CR34","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1007\/s00726-013-1648-0","volume":"46","author":"SM Hitzerd","year":"2014","unstructured":"Hitzerd SM, Verbrugge SE, Ossenkoppele G, Jansen G, Peters GJ (2014) Positioning of aminopeptidase inhibitors in next generation cancer therapy. Amino Acids 46:793\u2013808","journal-title":"Amino Acids"},{"key":"5102_CR35","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1021\/acs.bioconjchem.6b00136","volume":"27","author":"A Graziadio","year":"2016","unstructured":"Graziadio A, Zanda M, Frau S, Fleming IN, Musolino M, Dall\u2019Angelo S, Baldassarre M, Piras M (2016) NGR tumor-homing peptides: structural requirements for effective APN (CD13) targeting. Bioconjug Chem 27:1332\u20131340","journal-title":"Bioconjug Chem"},{"key":"5102_CR36","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.3390\/pharmaceutics14071414","volume":"14","author":"A Corti","year":"2022","unstructured":"Corti A, Calimeri T, Curnis F, Ferreri AJM (2022) Targeting the blood-brain tumor barrier with tumor necrosis factor-alpha. Pharmaceutics 14:1414","journal-title":"Pharmaceutics"},{"key":"5102_CR37","doi-asserted-by":"publisher","first-page":"3813","DOI":"10.1021\/acs.molpharmaceut.0c00579","volume":"17","author":"A Corti","year":"2020","unstructured":"Corti A, Gasparri AM, Sacchi A, Colombo B, Monieri M, Rrapaj E, Ferreri AJM, Curnis F (2020) NGR-TNF engineering with an N-terminal serine reduces degradation and post-translational modifications and improves its tumor-targeting activity. Mol Pharm 17:3813\u20133824","journal-title":"Mol Pharm"},{"key":"5102_CR38","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1002\/smll.201202310","volume":"9","author":"F Curnis","year":"2013","unstructured":"Curnis F, Sacchi A, Longhi R, Colombo B, Gasparri A, Corti A (2013) IsoDGR-tagged albumin: a new avb3 selective carrier for nanodrug delivery to tumors. Small 9:673\u2013678","journal-title":"Small"},{"key":"5102_CR39","doi-asserted-by":"publisher","first-page":"3905","DOI":"10.4049\/jimmunol.1301348","volume":"191","author":"J Subramani","year":"2013","unstructured":"Subramani J, Ghosh M, Rahman MM, Caromile LA, Gerber C, Rezaul K, Han DK, Shapiro LH (2013) Tyrosine phosphorylation of CD13 regulates inflammatory cell-cell adhesion and monocyte trafficking. J Immunol 191:3905\u20133912","journal-title":"J Immunol"},{"key":"5102_CR40","doi-asserted-by":"publisher","first-page":"108219","DOI":"10.1016\/j.isci.2023.108219","volume":"26","author":"FM Barnieh","year":"2023","unstructured":"Barnieh FM, Galuska SP, Loadman PM, Ward S, Falconer RA, El-Khamisy SF (2023) Cancer-specific glycosylation of CD13 impacts its detection and activity in preclinical cancer tissues. iScience 26:108219","journal-title":"iScience"},{"key":"5102_CR41","doi-asserted-by":"publisher","first-page":"4588","DOI":"10.1073\/pnas.0611653104","volume":"104","author":"R Rangel","year":"2007","unstructured":"Rangel R, Sun Y, Guzman-Rojas L, Ozawa MG, Sun J, Giordano RJ, Van Pelt CS, Tinkey PT, Behringer RR, Sidman RL, Arap W, Pasqualini R (2007) Impaired angiogenesis in aminopeptidase N-null mice. Proc Natl Acad Sci U S A 104:4588\u20134593","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5102_CR42","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1002\/ijc.21089","volume":"116","author":"YW Chang","year":"2005","unstructured":"Chang YW, Chen SC, Cheng EC, Ko YP, Lin YC, Kao YR, Tsay YG, Yang PC, Wu CW, Roffler SR (2005) CD13 (aminopeptidase N) can associate with tumor-associated antigen L6 and enhance the motility of human lung cancer cells. Int J Cancer 116:243\u2013252","journal-title":"Int J Cancer"}],"container-title":["Cellular and Molecular Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-023-05102-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00018-023-05102-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-023-05102-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,30]],"date-time":"2024-01-30T12:08:45Z","timestamp":1706616525000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00018-023-05102-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,30]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["5102"],"URL":"https:\/\/doi.org\/10.1007\/s00018-023-05102-1","relation":{},"ISSN":["1420-682X","1420-9071"],"issn-type":[{"value":"1420-682X","type":"print"},{"value":"1420-9071","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,30]]},"assertion":[{"value":"19 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publication"}},{"value":"In vivo studies on animal models were approved by the San Raffaele Institutional Animal Care and Use Committee, and by the Ministero della Salute of Italy (Author. 480\/2022PR - 1293).","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"68"}}